Show
Sort by
-
Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study
-
Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: A multicenter Belgian Phase II study
-
Gemcitabine and oxaliplatine (GEMOX) in gemcitabine-refractory advanced pancreatic cancer: a phase II study
-
Adjuvant gemcitabine (GEM) and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter belgian phase II study